Shan LIN, Jiu-mao LIN, Ling ZHANG, et al. Shexiang Tongxin Dropping Pill (麝香通心滴丸) Protects against Na2S2O4-Induced Hypoxia-Reoxygenation Injury in H9c2 Cells. [J]. Chinese Journal of Integrative Medicine 25(6):439-445(2019)
DOI:
Shan LIN, Jiu-mao LIN, Ling ZHANG, et al. Shexiang Tongxin Dropping Pill (麝香通心滴丸) Protects against Na2S2O4-Induced Hypoxia-Reoxygenation Injury in H9c2 Cells. [J]. Chinese Journal of Integrative Medicine 25(6):439-445(2019) DOI: 10.1007/s11655-018-2976-4.
Shexiang Tongxin Dropping Pill (麝香通心滴丸) Protects against Na2S2O4-Induced Hypoxia-Reoxygenation Injury in H9c2 Cells
摘要
Abstract
Objectives:
2
To investigate the protective effects of Shexiang Tongxin Dropping Pill (麝香通心滴丸
STP) on Na
2
S
2
O
4
-induced hypoxia-reoxygenation injury in cardiomyoblast H9c2 cells.
Methods:
2
The cell viability and levels of mRNA and protein expression in H9c2 cells were determined following Na
2
S
2
O
4
-induced hypoxia using Hoechst staining
annexin V/propidium iodide (PI) flow cytometry
real-time polymerase chain reaction and Western blot analysis.
Results:
2
STP pretreatment significantly increased the viability and inhibited aberrant morphological changes in H9c2 cardiomyoblast cells induced by Na
2
S
2
O
4
treatment (
P
<
0.05). In addition
STP pretreatment attenuated Na
2
S
2
O
4
-induced hypoxic damage
down-regulated the expression of pro-apoptotic Bax
and up-regulated the expression of anti-apoptotic Bcl-2 in H9c2 cells (
P
<
0.05).
Conclusions:
2
STP was strongly cardioprotective in hypoxia-reoxygenation injury by preventing hypoxic damage and inhibiting cellular apoptosis. These results further support the use of STP as an effective drug for the treatment of ischemic heart disease.